Emicizumab enhances the ex vivo coagulant potential in plasma samples from patients with von Willebrand disease
Int J Hematol. 2025 Nov 11. doi: 10.1007/s12185-025-04098-7. Online ahead of print. ABSTRACT BACKGROUND: von Willebrand disease (VWD) is a hereditary bleeding disorder caused by …